20 Jan 2025
// EXPRESSPHARMA
01 Jan 2025
// BUSINESS STD
04 Dec 2024
// BUSINESS STD
Latest Content by PharmaCompass
Strides Pharma Science: Pioneering IP-driven formulations for niche finished dosage forms.
About
Industry Trade Show
Not Confirmed
17-20 March, 2025
Industry Trade Show
Not Confirmed
20-21 January, 2025
Industry Trade Show
Not Confirmed
21-23 January, 2025
CONTACT DETAILS
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
17-20 March, 2025
Industry Trade Show
Not Confirmed
20-21 January, 2025
Industry Trade Show
Not Confirmed
21-23 January, 2025
CORPORATE CONTENT #SupplierSpotlight
20 Jan 2025
// EXPRESSPHARMA
https://www.expresspharma.in/strides-gains-usfda-approval-for-acetaminophen-and-ibuprofen-tablets-125-mg-250-mg/
01 Jan 2025
// BUSINESS STD
https://www.business-standard.com/markets/capital-market-news/strides-pharma-science-ltd-leads-gainers-in-a-group-125010100315_1.html
04 Dec 2024
// BUSINESS STD
https://www.business-standard.com/markets/capital-market-news/strides-pharma-science-ltd-leads-losers-in-a-group-124120400661_1.html
25 Nov 2024
// BUSINESS STD
https://www.business-standard.com/markets/capital-market-news/onesource-specialty-pharma-successfully-raises-rs-801-cr-via-equity-issuance-124112500703_1.html
25 Nov 2024
// PRESS RELEASE
https://strides.com/pdf/pressrelease/2024/StridesSEIntimation_25_Nov_2024.pdf
21 Nov 2024
// BUSINESS STD
https://www.business-standard.com/markets/capital-market-news/strides-pharma-jumps-on-securing-nclt-nod-for-onesource-124112100633_1.html
Inspections and registrations
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?